BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 12776285)

  • 1. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
    Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
    Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.
    Carraro M; Caridi G; Bruschi M; Artero M; Bertelli R; Zennaro C; Musante L; Candiano G; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2002 Jul; 13(7):1946-52. PubMed ID: 12089392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects.
    Weber S; Tönshoff B
    Transplantation; 2005 Sep; 80(1 Suppl):S128-34. PubMed ID: 16286890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
    Höcker B; Knüppel T; Waldherr R; Schaefer F; Weber S; Tönshoff B
    Pediatr Nephrol; 2006 Oct; 21(10):1476-9. PubMed ID: 16721582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis.
    Caridi G; Bertelli R; Carrea A; Di Duca M; Catarsi P; Artero M; Carraro M; Zennaro C; Candiano G; Musante L; Seri M; Ginevri F; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2001 Dec; 12(12):2742-2746. PubMed ID: 11729243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Transplant Recurrence of Focal Segmental Glomerulosclerosis in a Child With Heterozygous Mutations in NPHS1 and NPHS2.
    Battelino N; Arnol M; Kandus A; Ponikvar R; Novljan G
    Ther Apher Dial; 2016 Jun; 20(3):312-7. PubMed ID: 27312921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and mutational survey of NPHS2 (podocin) in Japanese children with focal segmental glomerulosclerosis who underwent renal transplantation.
    Furue T; Hattori M; Tsukaguchi H; Kitamura A; Oomori T; Ogino D; Nakakura H; Ashida A; Miura K; Hisano M; Takahashi K; Chikamoto H; Akioka Y; Sakano T
    Pediatr Transplant; 2008 May; 12(3):341-6. PubMed ID: 18208440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three siblings with steroid-resistant nephrotic syndrome: new NPHS2 mutations in a Turkish family.
    Ekim M; Ozçakar ZB; Acar B; Yüksel S; Yalçnkaya F; Tulunay O; Ensari A; Erbay B
    Am J Kidney Dis; 2004 Aug; 44(2):e22-24. PubMed ID: 15264208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NPHS2 mutation associated with recurrence of proteinuria after transplantation.
    Billing H; Müller D; Ruf R; Lichtenberger A; Hildebrandt F; August C; Querfeld U; Haffner D
    Pediatr Nephrol; 2004 May; 19(5):561-4. PubMed ID: 15015071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NPHS2 variation in focal and segmental glomerulosclerosis.
    Tonna SJ; Needham A; Polu K; Uscinski A; Appel GB; Falk RJ; Katz A; Al-Waheeb S; Kaplan BS; Jerums G; Savige J; Harmon J; Zhang K; Curhan GC; Pollak MR
    BMC Nephrol; 2008 Sep; 9():13. PubMed ID: 18823551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome.
    Oleggini R; Bertelli R; Di Donato A; Di Duca M; Caridi G; Sanna-Cherchi S; Scolari F; Murer L; Allegri L; Coppo R; Emma F; Camussi G; Perfumo F; Ghiggeri GM
    Gene Expr; 2006; 13(1):59-66. PubMed ID: 16572591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
    Doublier S; Zennaro C; Musante L; Spatola T; Candiano G; Bruschi M; Besso L; Cedrino M; Carraro M; Ghiggeri GM; Camussi G; Lupia E
    PLoS One; 2017; 12(11):e0188045. PubMed ID: 29155846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis.
    Laurin LP; Lu M; Mottl AK; Blyth ER; Poulton CJ; Weck KE
    Nephrol Dial Transplant; 2014 Nov; 29(11):2062-9. PubMed ID: 24500309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant recurrence of proteinuria in a case of focal segmental glomerulosclerosis associated with WT1 mutation.
    Ghiggeri GM; Aucella F; Caridi G; Bisceglia L; Ghio L; Gigante M; Perfumo F; Carraro M; Gesualdo L
    Am J Transplant; 2006 Sep; 6(9):2208-11. PubMed ID: 16780544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocin-related mechanisms in posttransplant [corrected] recurrence of focal segmental glomerulosclerosis [corrected].
    Caridi G; Dagnino M; Sanna-Cherchi S; Perfumo F; Ghiggeri GM
    Transplant Proc; 2006 Dec; 38(10):3486-90. PubMed ID: 17175312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies.
    Becker-Cohen R; Bruschi M; Rinat C; Feinstein S; Zennaro C; Ghiggeri GM; Frishberg Y
    Am J Transplant; 2007 Jan; 7(1):256-60. PubMed ID: 17109732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NPHS2 mutations in adult patients with primary focal segmental glomerulosclerosis.
    Monteiro EJ; Pereira AC; Pereira AB; Krieger JE; Mastroianni-Kirsztajn G
    J Nephrol; 2006; 19(3):366-71. PubMed ID: 16874699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children.
    Ohta T; Kawaguchi H; Hattori M; Komatsu Y; Akioka Y; Nagata M; Shiraga H; Ito K; Takahashi K; Ishikawa N; Tanabe K; Yamaguchi Y; Ota K
    Transplantation; 2001 Mar; 71(5):628-33. PubMed ID: 11292291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The podocin mutation R229Q and early recurrence (within the first year) of glomerular disease after renal transplantation.
    Mohey H; Thibaudin L; Laurent B; Berthoux F
    Ann Transplant; 2013 Aug; 18():436-42. PubMed ID: 23982418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation.
    Jungraithmayr TC; Hofer K; Cochat P; Chernin G; Cortina G; Fargue S; Grimm P; Knueppel T; Kowarsch A; Neuhaus T; Pagel P; Pfeiffer KP; Schäfer F; Schönermarck U; Seeman T; Toenshoff B; Weber S; Winn MP; Zschocke J; Zimmerhackl LB
    J Am Soc Nephrol; 2011 Mar; 22(3):579-85. PubMed ID: 21355056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.